The Lancet Public, H. (2024). Inequalities in cancer: a major public health concern. Lancet Public Health, 9(3), e147. https://doi.org/10.1016/s2468-2667(24)00029-x

Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. J Cancer Res Pract. 2017;4(4):127–9. https://doi.org/10.1016/j.jcrpr.2017.07.001.

Article  Google Scholar 

Upadhyay A. Cancer: an unknown territory; rethinking before going ahead. Genes Dis. 2021;8(5):655–61. https://doi.org/10.1016/j.gendis.2020.09.002.

Article  CAS  PubMed  Google Scholar 

Kansara S, et al. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer. Semin Cancer Biol. 2023;95:1–12. https://doi.org/10.1016/j.semcancer.2023.06.007.

Article  CAS  PubMed  Google Scholar 

Kim SY, et al. The roles and mechanisms of coding and noncoding RNA variations in cancer. Exp Mol Med. 2024;56(9):1909–20. https://doi.org/10.1038/s12276-024-01307-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmad M, et al. Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk. J Exp Clin Cancer Res. 2023;42(1):173. https://doi.org/10.1186/s13046-023-02741-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kristensen LS, et al. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188–206. https://doi.org/10.1038/s41571-021-00585-y.

Article  CAS  PubMed  Google Scholar 

Mahmoodi Chalbatani G, et al. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach. Int J Nanomedicine. 2019;14:3111–28. https://doi.org/10.2147/ijn.S200253.

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Nemati S. Long intergenic non-protein coding RNA 115 (Linc00115): a notable oncogene in human malignancies. Gene. 2024;897:148066. https://doi.org/10.1016/j.gene.2023.148066.

Article  CAS  PubMed  Google Scholar 

Martino MTD, Tagliaferri P, Tassone P. Microrna in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44(1):126. https://doi.org/10.1186/s13046-025-03391-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Brien J, et al. Overview of microrna biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. https://doi.org/10.3389/fendo.2018.00402.

Article  PubMed  Google Scholar 

Mishan MA, et al. Role of micrornas in the anticancer effects of the flavonoid luteolin: a systematic review. Eur J Cancer Prev. 2021;30(5):413–21. https://doi.org/10.1097/cej.0000000000000645.

Article  CAS  PubMed  Google Scholar 

Shademan B, et al. Micrornas as targets for cancer diagnosis: interests and limitations. Adv Pharm Bull. 2023;13(3):435–45. https://doi.org/10.34172/apb.2023.047.

Article  CAS  PubMed  Google Scholar 

Ghamlouche F, et al. Micrornas as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Transl Oncol. 2023;28:101613. https://doi.org/10.1016/j.tranon.2022.101613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menon A, et al. miRNA: a promising therapeutic target in cancer. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms231911502.

Article  PubMed  PubMed Central  Google Scholar 

Khazeei Tabari MA, et al. Noncoding RNA roles in pharmacogenomic responses to aspirin: new molecular mechanisms for an old drug. BioMed Res Int. 2021;2021:6830560. https://doi.org/10.1155/2021/6830560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasheminasabgorji E, et al. MiR-638: a promising cancer biomarker with therapeutic potential. Curr Mol Med. 2023;23(5):377–89. https://doi.org/10.2174/1566524022666220405125900.

Article  CAS  PubMed  Google Scholar 

Pandey M, et al. Role of micrornas in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188552. https://doi.org/10.1016/j.bbcan.2021.188552.

Article  CAS  PubMed  Google Scholar 

Khandan M, et al. The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review. Naunyn Schmiedebergs Arch Pharmacol. 2025. https://doi.org/10.1007/s00210-025-04078-y.

Article  PubMed  Google Scholar 

Magee P, Shi L, Garofalo M. Role of microRNAs in chemoresistance. Ann Transl Med. 2015;3(21):332. https://doi.org/10.3978/j.issn.2305-5839.2015.11.32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pavlíková L, et al. The roles of microRNAs in cancer multidrug resistance. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14041090.

Article  PubMed  Google Scholar 

Stasiak P, et al. The profile of microrna expression and potential role in the regulation of drug-resistant genes in doxorubicin and topotecan resistant ovarian cancer cell lines. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23105846.

Article  PubMed  PubMed Central  Google Scholar 

Sinha BK, Tokar EJ, Bushel PR. Elucidation of mechanisms of Topotecan-induced cell death in human breast MCF-7 cancer cells by gene expression analysis. Front Genet. 2020;11:775. https://doi.org/10.3389/fgene.2020.00775.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leavey PJ, et al. Phase III trial adding Vincristine-Topotecan-Cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: a Children’s Oncology Group report. J Clin Oncol. 2021;39(36):4029–38. https://doi.org/10.1200/jco.21.00358.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaeckle KA, et al. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases. Cancer Med. 2020;9(21):7935–42. https://doi.org/10.1002/cam4.3422.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rujkijyanont P, et al. Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study. BMC Cancer. 2019;19(1):961. https://doi.org/10.1186/s12885-019-6186-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Ioris MA, et al. Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series. Sci Rep. 2023;13(1):19295. https://doi.org/10.1038/s41598-023-44993-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mondal P, Meeran SM. Micrornas in cancer chemoresistance: the sword and the shield. Noncoding RNA Res. 2021;6(4):200–10. https://doi.org/10.1016/j.ncrna.2021.12.001.

Article  CAS